Basic Information
| LncRNA/CircRNA Name | circ_0011385 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | thyroid cancer |
| ICD-0-3 | C73.9 |
| Methods | qPCR |
| Sample | thyroid cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | Hsa_circ_0011385 upregulated in thyroid cancer; hsa_circ_0011385 knockdown inhibited thyroid cancer cell proliferation, migration and invasion, and promoted cell cycle arrest and apoptosis. |
| Pubmed ID | 32082079 |
| Year | 2020 |
| Title | Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p |
External Links
| Links for circ_0011385 | GenBank HGNC NONCODE |
| Links for thyroid cancer | OMIM COSMIC |